0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Smart Biopsy"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$4,950USDGBP
Smart Biopsy Devices Market Report 2025 - Product Thumbnail Image

Smart Biopsy Devices Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,750USDGBP
  • 4 Results (Page 1 of 1)
Loading Indicator

The Smart Biopsy market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. It is driven by the need for more accurate and efficient diagnosis of diseases, as well as the increasing demand for minimally invasive procedures. Smart Biopsy technology enables the collection of tissue samples from a patient with minimal discomfort and risk. It also allows for the collection of more precise and accurate samples, which can be used for a variety of diagnostic tests. Smart Biopsy technology is used in a variety of medical settings, including cancer diagnosis, cardiovascular disease diagnosis, and infectious disease diagnosis. It is also used in the diagnosis of neurological disorders, such as Alzheimer's disease. The Smart Biopsy market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, C.R. Bard, Hologic, and Roche Diagnostics. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more